He currently focuses his coverage on gaming law, white-collar crime, global money laundering, tribal gaming, politics, and regulation... Click for morePrediction markets tied to clinical trial results risk sabotaging critical drug development, according to a report from The New York Times. Prediction markets are allowing traders to wager on the outcomes of clinical trials and FDA drug-approval decisions. Currently, some of the markets offered by prediction platforms include whether the Food and Drug Administration (FDA) will approve drugs for lung, breast, pancreatic, and blood cancer. Participant BehaviorThere are concerns that these markets may cause trial participants to alter their behavior. “When clinical trial results are reduced to mere gambling odds, the risk of manipulating or misrepresenting data increases significantly.